Development of an HPLC–MS/MS method to determine janagliflozin in human plasma and urine: application in clinical study
- 1 September 2018
- journal article
- research article
- Published by Future Science Ltd in Bioanalysis
- Vol. 10 (17) , 1439-1454
Abstract
Aim: Janagliflozin is a novel, orally selective sodium-glucose co-transporter-2 (SGLT2) inhibitor, which showed good efficacy and safety in preclinical study. The objective of this study is to develop and validate the HPLC-MS/MS method to determine janagliflozin in both of human urine and plasma. Methods: Janagliflozin was separated on Waters Xbridge Phenyl C18 column and detected on API 4000 tandem mass spectrometer with ESI source in negative mode. Results: This method provided good linearity in the range of 5-5000 ng/ml and 5-1000 ng/ml in plasma and urine. The matrix effect and extraction recoveries across three concentration levels were consistent. Conclusion: This validated method is reliable and has been successfully applied to a first-in-human trial of janagliflozin in Chinese subjects.Keywords
This publication has 16 references indexed in Scilit:
- Sodium-glucose Cotransporter 2 Inhibitors: Glucose Lowering Against other Hypoglycemic AgentsCardiovascular & Hematological Disorders-Drug Targets, 2018
- Plasma Pharmacokinetic Determination of Canagliflozin and Its Metabolites in a Type 2 Diabetic Rat Model by UPLC-MS/MSMolecules, 2018
- Pharmacotherapy of type 2 diabetes: An updateMetabolism, 2018
- Development and validation of an LC–MS/MS method for the determination of tofogliflozin in plasma and its application to a pharmacokinetic study in ratsJournal of Chromatography B, 2016
- Sodium-glucose cotransporter-2 inhibition for the reduction of cardiovascular events in high-risk patients with diabetes mellitusEuropean Heart Journal, 2016
- A quantitative LC–MS/MS method for determining ipragliflozin, a sodium-glucose co-transporter 2 (SGLT-2) inhibitor, and its application to a pharmacokinetic study in ratsJournal of Chromatography B, 2015
- Selective Reaction Monitoring of Negative Electrospray Ionization Acetate Adduct Ions for the Bioanalysis of Dapagliflozin in Clinical StudiesAnalytical Chemistry, 2015
- Rapid determination of canagliflozin in rat plasma by UHPLC–MS/MS using negative ionization mode to avoid adduct-ions formationTalanta, 2015
- Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of DiabetesDiabetes Care, 2014
- Validated LC–MS/MS Methods for The Determination of Dapagliflozin, A Sodium-Glucose Co-Transporter 2 Inhibitor in Normal and ZDF Rat PlasmaBioanalysis, 2010